Can we predict who gets severe COVID? luxembourg study seeks answers
NCT ID NCT04380987
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study followed 1,366 adults in Luxembourg who tested positive for COVID-19. Researchers tracked symptoms and took blood, swab, and stool samples to identify factors linked to severe disease. The goal was to better predict patient outcomes and improve care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict which COVID-19 patients are at risk of severe illness, enabling earlier and more targeted care.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot directly improve outcomes. The findings may not apply to other populations or virus variants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Luxembourg Institute of Health
Luxembourg, Luxembourg
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a different way of pedaling rebuild muscles after severe COVID-19?
- Ancient herbs take on long COVID: a trial tests whether chinese medicine can soothe persistent fatigue
- Can a 15-Minute chat at a testing site boost COVID-19 vaccination?
- E-Ink screens in ERs could boost patient satisfaction
- Massive study tracks how lockdowns shaped mental health across america
- Hidden danger: study probes blood clot risk in cancer patients with COVID-19